These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 31214189
1. Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells. Wang T, Zheng N, Luo Q, Jiang L, He B, Yuan X, Shen L. Front Immunol; 2019; 10():1235. PubMed ID: 31214189 [Abstract] [Full Text] [Related]
2. Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. Gao G, Ma T, Zhang T, Jin H, Li Y, Kwok LY, Zhang H, Sun Z. Front Immunol; 2021; 12():772532. PubMed ID: 34970262 [Abstract] [Full Text] [Related]
3. Lactobacillus reuteri Ameliorates Intestinal Inflammation and Modulates Gut Microbiota and Metabolic Disorders in Dextran Sulfate Sodium-Induced Colitis in Mice. Wang G, Huang S, Cai S, Yu H, Wang Y, Zeng X, Qiao S. Nutrients; 2020 Jul 31; 12(8):. PubMed ID: 32751784 [Abstract] [Full Text] [Related]
4. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. Gao C, Major A, Rendon D, Lugo M, Jackson V, Shi Z, Mori-Akiyama Y, Versalovic J. mBio; 2015 Dec 15; 6(6):e01358-15. PubMed ID: 26670383 [Abstract] [Full Text] [Related]
9. Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes. Li L, Fang Z, Liu X, Hu W, Lu W, Lee YK, Zhao J, Zhang H, Chen W. PLoS One; 2020 Jan 15; 15(4):e0231865. PubMed ID: 32315360 [Abstract] [Full Text] [Related]
10. Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells. Anderson R, Theron AJ, Rapoport BL. Front Immunol; 2019 Jan 15; 10():2254. PubMed ID: 31616428 [Abstract] [Full Text] [Related]
11. Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. Lin C, Zheng Y, Lu J, Zhang H, Wang G, Chen W. Life Sci; 2023 Feb 01; 314():121309. PubMed ID: 36563843 [Abstract] [Full Text] [Related]
13. Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models. Öhnstedt E, Doñas C, Parv K, Pang Y, Lofton Tomenius H, Carrasco López M, Gannavarapu VR, Choi J, Ovezik M, Frank P, Jorvid M, Roos S, Vågesjö E, Phillipson M. Am J Physiol Gastrointest Liver Physiol; 2024 Aug 01; 327(2):G140-G153. PubMed ID: 38780469 [Abstract] [Full Text] [Related]
15. Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model. Zhuo Q, Yu B, Zhou J, Zhang J, Zhang R, Xie J, Wang Q, Zhao S. Sci Rep; 2019 Dec 27; 9(1):20128. PubMed ID: 31882868 [Abstract] [Full Text] [Related]
16. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailón E, Nieto A, Concha A, Olivares M, Zarzuelo A, Xaus J, Gálvez J. Br J Nutr; 2007 Jan 27; 97(1):96-103. PubMed ID: 17217564 [Abstract] [Full Text] [Related]
19. Lactobacillus reuteri inhibits Staphylococcus aureus-induced mastitis by regulating oxytocin releasing and gut microbiota in mice. He Z, Li W, Yuan W, He Y, Xu J, Yuan C, Zhao C, Zhang N, Fu Y, Hu X. FASEB J; 2024 Jan 31; 38(2):e23383. PubMed ID: 38197892 [Abstract] [Full Text] [Related]
20. Ligilactobacillus salivarius CCFM 1266 modulates gut microbiota and GPR109a-mediated immune suppression to attenuate immune checkpoint blockade-induced colitis. Yan S, Yu L, Tian F, Zhao J, Chen W, Chen H, Zhai Q. Food Funct; 2023 Nov 27; 14(23):10549-10563. PubMed ID: 37953676 [Abstract] [Full Text] [Related] Page: [Next] [New Search]